Measurable blood proteins, cell counts, or molecules that quantify the presence, severity, and chronicity of inflammatory processes. Include acute phase proteins (C-reactive protein, Serum amyloid A, fibrinogen, Ferritin), inflammatory cytokines (Interleukin-6, TNF-α, IL-1β), and cell ratios (Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio). These markers reflect upstream immune activation and predict downstream tissue damage, metabolic dysfunction, and treatment responsiveness across psychiatric, metabolic, cardiovascular, and autoimmune conditions.
Think of inflammatory markers as the smoke alarms in a building. C-reactive protein is the central fire alarm that goes off loudest and fastest—within hours of detecting smoke (tissue damage or infection), it screams at 100-1000 times normal volume and keeps ringing until the fire is out. Interleukin-6 is the building manager who calls the fire department—it coordinates the emergency response but also decides when to start cleanup. Ferritin is the security guard who locks up all the iron (fuel) so looters (bacteria) can't steal it during chaos. Fibrinogen is the emergency sealant sprayed everywhere to patch holes and prevent flooding. The Neutrophil-lymphocyte ratio is like counting how many firefighters (neutrophils) versus inspectors (lymphocytes) are on site—if you have 3+ firefighters for every inspector, the building is either burning or the fire department is overreacting to a false alarm (chronic stress). Some alarms are temporary (acute inflammation)—they shut off when the fire is out. Others get stuck in the "on" position (chronic inflammation), beeping forever even after the flames are gone, slowly damaging the building with constant noise and unnecessary water damage.
graph TD
A[Inflammatory Stimulus] -->|PAMPs, DAMPs, stress| B[Leukocyte Activation]
B --> C[Cytokine Release]
C -->|"IL-6, IL-1β, TNF-α"| D[Hepatocyte Receptors]
D -->|"JAK-STAT & NF-κB"| E[Acute Phase Protein Synthesis]
E --> F["CRP ↑100-1000x"]
E --> G["SAA ↑1000x"]
E --> H["Fibrinogen ↑2-4x"]
E --> I["Ferritin ↑"]
C -->|IL-6| J[Sympathetic Activation]
J -->|Cortisol| K[Neutrophil Mobilization]
J -->|Cortisol| L[Lymphocyte Suppression]
K --> M["NLR ↑"]
L --> M
F -->|Binds phosphocholine| N[Complement Activation]
N --> O[Opsonization & Pathogen Clearance]
I -->|Sequesters iron| P[Iron Unavailable to Pathogens]
H --> Q["↑Blood Viscosity & Clotting"]
Upstream activation cascade:
- Inflammatory stimuli (PAMPs, DAMPs, psychological stress, tissue injury, pathogens) → pattern recognition receptors (TLR4, NOD-Like Receptors) on dendritic cells, macrophages, neutrophils
- Receptor activation → NF-κB translocation + NLRP3 inflammasome assembly
- Transcription of pro-inflammatory cytokine genes: IL6, TNF, IL1B
- Secretion of IL-1β (via caspase-1 cleavage), TNF-α, Interleukin-6
Hepatic acute phase response:
- Interleukin-6 binds IL-6R (gp80) + gp130 on hepatocytes
- JAK1/JAK2 phosphorylation → STAT3 dimerization → nuclear translocation
- Parallel pathway: TNF-α and IL-1β activate NF-κB via IκB degradation
- Combined STAT3 + NF-κB → transcription of acute phase proteins:
- C-reactive protein: 100-1000-fold increase within 24-48 hours, doubles every 8 hours, peaks at 48h
- Serum amyloid A: 1000-fold increase, transports cholesterol to HDL
- Fibrinogen: 2-4-fold increase, elevates blood viscosity and ESR
- Ferritin: 2-5-fold increase, sequesters iron via ferroportin downregulation
CRP mechanism:
- Pentameric structure binds phosphocholine on damaged cell membranes and bacterial surfaces
- Activates classical complement pathway via C1q binding
- Opsonization → enhanced phagocytosis by macrophages and neutrophils
- Half-life: 19 hours (constant synthesis determines level, not clearance)
Neutrophil-lymphocyte ratio:
Cytokine kinetics:
- TNF-α: half-life ~20 min, peaks 90 min post-stimulus, difficult to measure clinically
- IL-1β: half-life ~6 min, local autocrine/paracrine effects dominate
- Interleukin-6: half-life ~60 min, measurable systemically, peaks 2-6 hours, sustained elevation indicates chronic activation
Treatment selection in psychiatry:
Cardiovascular risk stratification:
Infectious vs non-infectious inflammation:
- CRP >100 mg/L strongly suggests bacterial infectious disease (sensitivity ~90%)
- CRP 5-50 mg/L: ambiguous (could be viral, autoimmune, or severe metabolic inflammation)
- Procalcitonin superior for bacterial infection specificity (>0.5 ng/mL suggests bacterial sepsis)
- Clinical implication: guides antibiotic stewardship—high CRP + low procalcitonin suggests non-infectious inflammation
Ferritin as inflammation marker:
Neutrophil-lymphocyte ratio applications:
Monitoring intervention effectiveness:
Evolutionary mismatch connection:
- CRP increases 100-1000-fold in acute inflammation, doubling every 8 hours, peaking at 48 hours post-insult
- CRP <1 mg/L = low cardiovascular risk; 1-3 mg/L = average risk; >3 mg/L = high risk (Framingham-derived thresholds)
- CRP >5 mg/L suggests active infectious disease or severe inflammatory disease (RA flare, IBD exacerbation)
- IL-6 >5 pg/mL predicts 50% lower antidepressant response rate and doubles cardiovascular event risk over 10 years
- IL-6 levels: healthy <1.5 pg/mL, chronic inflammation 2-5 pg/mL, acute infection/sepsis >50 pg/mL
- TNF-α half-life ~20 minutes makes it impractical for routine clinical measurement (unstable ex vivo)
- Neutrophil-lymphocyte ratio >3 predicts increased mortality across diverse conditions; >5 indicates severe inflammatory state
- Ferritin >300 ng/mL (men) or >200 ng/mL (women) suggests inflammation unless iron studies confirm overload
- ESR correlates with fibrinogen level (r=0.7) but slower to change than CRP (weeks vs hours)
- SAA increases 1000-fold in acute inflammation, promotes cholesterol efflux but also amyloid formation (chronic elevation → amyloidosis risk)
- CRP half-life of 19 hours means levels reflect synthesis rate—persistently elevated CRP indicates ongoing stimulus
- Mediterranean diet + exercise reduces CRP by 40-50% over 6 months in metabolic syndrome patients
- Omega-3 index >8% reduces IL-6 by 20-30% and CRP by 15-25% (mechanism: resolvin/protectin synthesis)
- NLR correlates with cortisol awakening response (r=0.6) and HRV (r=-0.5)—direct autonomic-immune link
- C-reactive protein — most clinically used and fastest responding marker among
- Interleukin-6 — master regulator cytokine driving hepatic synthesis of
- TNF-α — proximal inflammatory cytokine triggering cascade producing
- IL-1β — inflammasome-derived cytokine synergizing with IL-6 to induce
- Ferritin — iron storage protein elevated as acute phase reactant among
- Neutrophil-lymphocyte ratio — easily calculated stress-immune index among
- acute phase response — coordinated hepatic synthesis program producing
- fibrinogen — coagulation protein and ESR determinant among
- Serum amyloid A — most dramatically elevated (1000x) marker among
- ESR — indirect measure of fibrinogen and other markers, slower than CRP
- Procalcitonin — bacterial infection-specific marker compared with non-specific
- depression — CRP >3 mg/L predicts treatment-resistant subtype, guides therapy selection
- cardiovascular disease — CRP independently predicts events, guides statin therapy
- chronic stress — elevates NLR and IL-6 via sympathetic-HPA activation
- Cortisol — mobilizes neutrophils and suppresses lymphocytes, driving NLR elevation
- obesity — visceral adipose tissue chronically secretes IL-6, elevating all markers
- sleep deprivation — single night increases IL-6 by 40%, CRP by 25%
- gut dysbiosis — LPS translocation activates TLR4, inducing cytokine synthesis
- chronic inflammation — persistently elevated markers (CRP >3 mg/L) define this state
- exercise — acutely increases IL-6 (myokine function), chronically reduces CRP by 30-40%
- metabolic syndrome — characterized by CRP >3 mg/L, IL-6 >2 pg/mL, high ferritin
- Allostatic load — cumulative inflammatory burden measured via composite marker scores
- NF-κB — transcription factor mediating cytokine-induced acute phase protein synthesis
- JAK-STAT — signaling pathway through which IL-6 induces CRP and SAA
- complement — activated by CRP binding to damaged cells, amplifying inflammation
- hepcidin — IL-6-induced peptide that elevates ferritin by trapping intracellular iron
- anemia of chronic disease — caused by IL-6-hepcidin axis preventing iron mobilization
- sympathetic nervous system — activation increases NLR via catecholamine-induced neutrophil mobilization
- vagus nerve — cholinergic anti-inflammatory pathway reduces cytokine synthesis, lowers markers
- omega-3 fatty acids — substrate for resolvins/protectins, reduces IL-6 and CRP synthesis
- Mediterranean diet — reduces inflammatory markers 20-40% via polyphenols, omega-3, low AGEs
- atherosclerosis — CRP deposits in plaques, predicts rupture risk independent of lipids
- diabetes — chronic hyperglycemia elevates AGEs, inducing IL-1β and sustained inflammation
- autoimmune disease — often shows paradoxically normal CRP (IL-6 drives pathology without acute phase response in some conditions)
- COVID-19 — IL-6 >80 pg/mL and CRP >100 mg/L predict cytokine storm and poor outcomes
- resolution of inflammation — successful resolution marked by return of CRP <1 mg/L, IL-6 <2 pg/mL
- specialized pro-resolving mediators — resolvins/protectins actively lower inflammatory markers by terminating NF-κB signaling